KR102343166B1 - Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid - Google Patents

Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid Download PDF

Info

Publication number
KR102343166B1
KR102343166B1 KR1020210071390A KR20210071390A KR102343166B1 KR 102343166 B1 KR102343166 B1 KR 102343166B1 KR 1020210071390 A KR1020210071390 A KR 1020210071390A KR 20210071390 A KR20210071390 A KR 20210071390A KR 102343166 B1 KR102343166 B1 KR 102343166B1
Authority
KR
South Korea
Prior art keywords
salicylic acid
tea tree
buckwheat
leaf
skin
Prior art date
Application number
KR1020210071390A
Other languages
Korean (ko)
Inventor
정의성
이종섭
박민희
이은모
오영주
강성민
최유선
정은지
Original Assignee
주식회사 단정바이오
(주)360 퍼스펙티브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 단정바이오, (주)360 퍼스펙티브 filed Critical 주식회사 단정바이오
Priority to KR1020210071390A priority Critical patent/KR102343166B1/en
Application granted granted Critical
Publication of KR102343166B1 publication Critical patent/KR102343166B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regeneration, elasticity, and moisturizing effects containing a mixing extract of a tea tree leaf, an artemisia princeps leaf, a buckwheat seed, and a capryloyl salicylic acid as active ingredients, and more specifically, to comprise a mixing extract of a tea tree leaf, an artemisia princeps leaf, a buckwheat seed, and a capryloyl salicylic acid as active ingredients. The mixing extract of the tea tree leaf, the artemisia princeps leaf, the buckwheat seed, and the capryloyl salicylic acid is extracted by mixing the tea tree leaf, the artemisia princeps leaf, the buckwheat seed, and the capryloyl salicylic acid in a weight ratio of 0.0001-40.0%, respectively. The cosmetic composition according to the present invention provides a skin antioxidant effect; provides the skin anti-inflammatory, skin soothing, regeneration, elasticity, and moisturizing effects; and provides no skin irritation and no side effects.

Description

티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 함유한 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 갖는 화장료 조성물 {Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid}Cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects containing tea tree leaves, mugwort, buckwheat and capryloyl salicylic acid {Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration , elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid}

본 발명은 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 함유하여 항산화, 항염, 피부진정, 재생, 탄력 및 보습효과를 지닌 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract as an active ingredient to have antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects.

인체의 피부는 신체를 구성하는 기관 중에서도 가장 큰 기관으로 보통 표피층, 진피층, 피하지방층으로 구분한다. 피부는 늘 외부환경에 직접적으로 노출되어 있어서 환경 변화에 따라 다양한 자극을 받을 수 있으며, 그에 따른 스트레스나 방어기작으로 인하여 다양한 피부 질환이 발현되기도 한다. 피부는 인체의 최외곽 기관으로서 제1차 생체 보호막의 기능을 담당하는데, 인체 내의 수분 손실을 막아주고, 그와 동시에 외부로부터 유입될 수 있는 각종 유해물질이나 오염물질의 침투를 차단하고, 자외선으로부터 보호해주며, 추운 환경에서는 수축을 통해서 열손실을 낮춰주고, 더운 환경에서는 땀을 배출하여 체열을 발산함으로써 인체의 항상성을 유지하는데 중요한 역할을 수행한다.The skin of the human body is the largest organ among the organs constituting the body and is usually divided into the epidermis, dermis, and subcutaneous fat layer. Since the skin is always directly exposed to the external environment, it can receive various stimuli according to changes in the environment. As the outermost organ of the human body, the skin is responsible for the function of the first biological protective film, preventing moisture loss in the human body, and at the same time blocking the penetration of various harmful substances or contaminants that can be introduced from the outside, and protects the skin from UV rays. In a cold environment, it lowers heat loss through contraction, and in a hot environment, it plays an important role in maintaining the homeostasis of the human body by dissipating body heat by dissipating sweat.

이러한 피부는 심각한 미세먼지나 다양한 공해물질 또는 급격한 온도변화와 같은 변화무상한 외부환경적 요인, 찰과상이나 강한 태양 자외선과 같은 물리적 요인, 모기, 벌, 진드기와 같은 벌레물림 또는 옻나무 수액접촉과 같은 생물학적 요인, 세균성 미생물 감염 등 이상과 같은 다양한 요인들로 인하여 내분비계의 이상이나, 피부면역체계의 과민반응으로 인해 피부트러블, 건조증, 소양증(가려움증), 자극, 버닝(Burning), 염증, 부종 등의 여러 가지 피부 질환들이 표출될 수 있다.Such skin is sensitive to severe fine dust, various pollutants, or unchanging external environmental factors such as sudden temperature changes, physical factors such as abrasions or strong ultraviolet rays from the sun, insect bites such as mosquitoes, bees and ticks, or biological factors such as contact with poison ivy sap. Due to various factors such as factors, bacterial infection, etc., abnormalities of the endocrine system or hypersensitivity of the skin immune system can cause skin problems, dryness, pruritus (itch), irritation, burning, inflammation, edema, etc. Various skin diseases can be expressed.

이러한 피부에 악영향을 미치는 요소들로부터 피부를 보호하기 위하여 항산화, 항염, 피부진정, 재생, 탄력 및 보습효과를 지닌 화장료 조성물에 대한 필요성이 커지고 있는 추세다.In order to protect the skin from factors that adversely affect the skin, the need for a cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects is increasing.

상기와 같은 문제와 관련된 종래의 기술로는 대한민국 등록특허공보 제10-2033088호(2019.10.17.)에 "식물 추출 혼합물을 포함하는 항균, 항염, 항산화, 피지분비억제 및 피부염 개선용 조성물"이 개시된 바 있는데, 이는 식물 추출 혼합물을 포함하는 항균, 항염, 항산화, 피지분비억제 및 피부염 개선용 조성물에 관한 것으로, 보다 구체적으로 꿀풀(Prunella vulgaris), 자목련(Magnolia liliflora), 돌콩(Glycine soya), 감초(Glycyrrhiza glabra), 병풀(Centella asiatica)의 다섯 가지 식물 추출물의 혼합물을 유효성분으로 포함하는 항균, 항염, 항산화, 피지분비억제 및 피부염 개선용 조성물에 관한 것이다.As a prior art related to the above problems, in Korean Patent Publication No. 10-2033088 (2019.10.17.), "Antibacterial, anti-inflammatory, antioxidant, sebum secretion inhibition and dermatitis improvement composition containing plant extract mixture" As disclosed, it relates to a composition for antibacterial, anti-inflammatory, antioxidant, sebum secretion inhibition and dermatitis improvement comprising a plant extract mixture, and more specifically, Prunella vulgaris, Magnolia liliflora, Glycine soya, It relates to a composition for antibacterial, anti-inflammatory, antioxidant, sebum secretion inhibition and dermatitis improvement comprising a mixture of five plant extracts of licorice (Glycyrrhiza glabra) and centella asiatica as an active ingredient.

그러나, 상기 종래의 기술은 효과가 미미하였으며, 보다 월등한 효과를 갖는 조성물에 대한 필요성이 커지고 있었다.However, the effect of the prior art was insignificant, and the need for a composition having a superior effect was growing.

대한민국 등록특허공보 제10-2033088호(2019.10.17.), "식물 추출 혼합물을 포함하는 항균, 항염, 항산화, 피지분비억제 및 피부염 개선용 조성물"Republic of Korea Patent Publication No. 10-2033088 (2019.10.17.), "Composition containing plant extract mixture for antibacterial, anti-inflammatory, antioxidant, sebum secretion inhibition and dermatitis improvement"

따라서, 본 발명의 목적은 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 함유하는 항산화, 항염, 피부진정, 재생, 탄력 및 보습효과를 지닌 화장료 조성물에 관한 것이다.Accordingly, an object of the present invention relates to a cosmetic composition containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract as an active ingredient, having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects.

상기와 같은 과제를 달성하기 위하여 본 발명은 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 하는 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 함유한 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 갖는 화장료 조성물을 제공한다.In order to achieve the above object, the present invention is an antioxidant containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid, which contains a tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract as an active ingredient. , to provide a cosmetic composition having anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects.

또한, 상기 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물은, 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 각각 0.0001 ~ 40.0%의 중량비로 혼합하여 추출한 것을 특징으로 한다.In addition, the tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract is extracted by mixing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid in a weight ratio of 0.0001 to 40.0%, respectively. do.

또한, 상기 추출물은 물, 탄소수 1 내지 4개의 무수 또는 함수 저급 알코올, 에틸 아세테이트, 글리세린 및 에틸렌글리콜로 구성된 군으로부터 선택되는 어느 하나 또는 둘 이상 혼합된 추출 용매를 사용하여 추출하는 것을 특징으로 한다.In addition, the extract is characterized in that it is extracted using any one or a mixture of two or more extraction solvents selected from the group consisting of water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, ethyl acetate, glycerin and ethylene glycol.

또한, 상기 화장료 조성물은 화장수, 스킨, 로션, 크림, 파운데이션, 에센스, 젤, 팩, 유화형 자외선 차단용 크림, 유화형 파운데이션, 유화형 메이크업 베이스, 오일케익형 파운데이션, 투웨이케익, 또는 파우더 팩트의 제형으로 제형화하는 것을 특징으로 한다.In addition, the cosmetic composition is a lotion, skin, lotion, cream, foundation, essence, gel, pack, emulsified sunscreen cream, emulsified foundation, emulsified makeup base, oil cake-type foundation, two-way cake, or powder pact. It is characterized in that it is formulated in a dosage form.

본 발명에 따른 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 함유하는 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 제공하는데 있다.It is to provide antioxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects containing the tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract according to the present invention as an active ingredient.

도 1은 본 발명에 따른 시료 처리농도별 세포 생존율을 평가한 그래프.
도 2는 본 발명에 따른 시료 처리농도별 라디칼소거 효과를 평가한 그래프.
도 3은 본 발명에 따른 시료 처리농도별 NO 생성 저해를 평가한 그래프.
도 4는 본 발명에 따른 시료 처리별 피부진정 효과를 평가한 그래프.
도 5는 본 발명에 따른 시료 처리별 피부보습효과를 평가한 그래프.
도 6는 본 발명에 따른 시료 처리별 경피수분손실량을 나타낸 그래프.
도 7은 본 발명에 따른 시료의 피부탄력개선효과를 나타낸 그래프.
1 is a graph evaluating the cell viability for each sample treatment concentration according to the present invention.
2 is a graph evaluating the radical scavenging effect for each sample treatment concentration according to the present invention.
3 is a graph evaluating the inhibition of NO production by sample treatment concentration according to the present invention.
4 is a graph evaluating the skin soothing effect for each sample treatment according to the present invention.
5 is a graph evaluating the skin moisturizing effect for each sample treatment according to the present invention.
6 is a graph showing the amount of transdermal water loss for each sample treatment according to the present invention.
7 is a graph showing the skin elasticity improvement effect of the sample according to the present invention.

이하의 본 발명에 관한 상세한 설명들은 본 발명이 실시될 수 있는 실시 예이고 해당 실시 예의 예시로써 도시된 첨부 도면을 참조한다. 이들 실시 예는 당 업자가 본 발명의 실시에 충분하도록 상세히 설명된다. 본 발명의 다양한 실시 예는 서로 다르지만 상호 배타적일 필요는 없음이 이해되어야 한다. 예를 들어, 여기에 기재되어 있는 특정 형상, 구조 및 특성은 일 실시 예에 관련하여 본 발명의 사상 및 범위를 벗어나지 않으면서 다른 실시 예로 구현될 수 있다. 또한, 각각의 기재된 실시 예 내의 개별 구성요소의 위치 또는 배치는 본 발명의 사상 및 범위를 벗어나지 않으면서 변경될 수 있음이 이해되어야 한다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The following detailed description of the present invention is an embodiment in which the present invention may be practiced, and reference is made to the accompanying drawings shown by way of example of the embodiment. These embodiments are described in sufficient detail to enable those skilled in the art to practice the present invention. It should be understood that various embodiments of the present invention are different but need not be mutually exclusive. For example, specific shapes, structures, and characteristics described herein may be implemented in other embodiments without departing from the spirit and scope of the present invention in relation to one embodiment. In addition, it should be understood that the position or arrangement of individual components in each described embodiment may be changed without departing from the spirit and scope of the present invention.

따라서 후술되는 상세한 설명은 한정적인 의미로서 취하려는 것이 아니며, 본 발명의 범위는 적절하게 설명된다면 그 청구항들이 주장하는 것과 균등한 모든 범위와 더불어 첨부된 청구항에 의해서만 한정된다. 도면에서 유사한 참조부호는 여러 측면에 걸쳐서 동일하거나 유사한 기능을 지칭한다.Accordingly, the detailed description set forth below is not intended to be taken in a limiting sense, and the scope of the present invention, if properly described, is limited only by the appended claims, along with all scopes equivalent to those claimed by the claims. Like reference numerals in the drawings refer to the same or similar functions throughout the various aspects.

본 발명에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.The terms used in the present invention have been selected as currently widely used general terms as possible while considering the functions in the present invention, but these may vary depending on the intention or precedent of a person skilled in the art, the emergence of new technology, and the like. In addition, in a specific case, there is a term arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the corresponding invention. Therefore, the term used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, rather than the name of a simple term.

본 발명에서 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.In the present invention, when a part "includes" a certain component, it means that other components may be further included, not excluding other components, unless otherwise stated.

본 발명은 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 유효성분으로 함유하여 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 지닌 화장료 조성물을 제공한다.The present invention provides a cosmetic composition containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid as active ingredients to have antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects.

상기 "티트리(Melaleuca Alternifolia (Tea Tree))"는 티트리는 도금양목 도금양과에 속하는 상록교목으로써, 잎은 선형이고 꽃은 희색으로 피는 작은 관목이다. 티트리에는 Terpinen, cymene, cineol, pinene, sabinene과 같은 여러 성분들을 함유하고 있어 항산화, 항염, 항균, 피부재생, 피부보습 및 진정 등에 대한 효과가 있다 알려져 있다.The "tea tree (Melaleuca Alternifolia (Tea Tree)") is an evergreen arboreal tree belonging to the genus oleifera family, and is a small shrub with linear leaves and white flowers. Tea tree contains various ingredients such as terpinen, cymene, cineol, pinene, and sabinene, and is known to have antioxidant, anti-inflammatory, antibacterial, skin regeneration, skin moisturizing and soothing effects.

상기 "쑥(Artemisia Princeps Leaf)"은 국화과(Compositae)에 속하는 다년초로, 전호를 말린 것을 애엽 또는 애호라고 불린다. 약쑥은 부위와 시기에 따라 사용용도가 다양하며 특히 줄기와 잎은 약용, 어린잎은 식용으로, 일반적인 잎은 뜸쑥을 만들 때 사용한다고 알려져있다. 약쑥에는 acetylene, sesquiterpene lactone, eupatilin, caffeic acid, catechol, protocatechunic acid 등의 유효성분으로 함유되어 있으며, 이러한 성분을 바탕으로 쑥 추출물에는 항산화 활성, 항염 효능이 있는 것으로 알려져 있다.The "wormwood (Artemisia Princeps Leaf)" is a perennial plant belonging to the Asteraceae (Compositae). It is known that medicinal mugwort has various uses depending on the part and time of year, and in particular, the stem and leaves are medicinal, young leaves are edible, and the general leaves are used to make moxa. Wormwood contains active ingredients such as acetylene, sesquiterpene lactone, eupatilin, caffeic acid, catechol, and protocatechunic acid. Based on these ingredients, mugwort extract is known to have antioxidant and anti-inflammatory properties.

상기 "메밀(Polygonum Fagopyrum (Buckwheat) Seed)는 마디풀과에 속하는 일년초로 분류학상 밀이나 곡류와 구별되면서도 곡류의 범주에 포함시키고 있다. 특히, 메밀에는 Rutin 성분이 다량으로 함유되어 있어 항산화, 항염 및 세포생장에 영향을 재생 등 대표적인 생리활성을 보이고 있다. 또한, 메밀은 피부 아토피와 보습에 효과적이라고 알려져있다.The "buckwheat (Polygonum Fagopyrum (Buckwheat) Seed) is an annual plant belonging to the family Knobaceae and is classified taxonomically from wheat or cereals, but is included in the category of cereals. In particular, buckwheat contains a large amount of Rutin, so it has antioxidant, anti-inflammatory and It affects cell growth and exhibits typical physiological activities such as regeneration, etc. Also, buckwheat is known to be effective for skin atopy and moisturizing.

상기 "카프릴로일살리실릭애씨드(Capryloyl Salicylic Acid)"는 로레알에 의해 개발된 살리실릭애씨드의 유도체로 살리실릭애씨드의 벤젠고리에 지방사슬을 결합시켜 만든 것이다. pH 5.5로 정상피부와 거의 흡사하여 자극이 없어 중화시킬 필요가 없으며 지용성의 성질로 피부에 서서히 침투하여 각질제거, 피지제거, 항균과 항염효과도 우수한 것으로 알려져있다.The "Capryloyl Salicylic Acid" is a derivative of salicylic acid developed by L'Oreal, and is made by bonding a fatty chain to the benzene ring of salicylic acid. With a pH of 5.5, it is almost similar to normal skin, so there is no need to neutralize it, and it is known to be excellent in exfoliation, sebum removal, antibacterial and anti-inflammatory effects by slowly penetrating the skin due to its oil-soluble nature.

본 발명에서 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 모두 우수한 항산화 활성효과를 가지고 있으며, 상기 추출물 중 최소 2개 이상의 혼합물, 바람직하게 티트리잎추출물, 쑥추출물, 메밀추출물 및 카프릴로일살리실릭애씨드는 우수한 시너지효과를 지님을 발견하였다.In the present invention, tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid all have excellent antioxidant activity, and a mixture of at least two of the extracts, preferably tea tree leaf extract, mugwort extract, buckwheat extract and caprylo Ilsalicylic acid was found to have an excellent synergistic effect.

특히, 항산화, 항염, 피부진정, 재생, 탄력 및 보습효과를 부여하기 위하여 티트리잎추출물, 쑥추출물, 메밀추출물 및 카프릴로일살리실릭애씨드를 유효성분으로 사용하였다. In particular, tea tree leaf extract, mugwort extract, buckwheat extract and capryloyl salicylic acid were used as active ingredients to impart antioxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects.

본 발명의 바람직한 구현 예에 따르면, 본 발명인 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 혼합하여 추출한 원물의 혼합비율은 아래와 같은 비율로 포함될 수 있다.According to a preferred embodiment of the present invention, the mixing ratio of the raw material extracted by mixing the present invention tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid may be included in the following ratio.

상기 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물은, 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 각각 0.0001 ~ 40.0%의 중량비로 혼합하여 추출한 것이 바람직하다. 보다 구체적으로, 상기 티트리잎 : 쑥 : 메밀 : 카프릴로일살리실릭애씨드의 중량비는 33.334 : 33.334 : 33.331 : 0.001로 구성될 수 있다.The tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract is preferably extracted by mixing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid in a weight ratio of 0.0001 to 40.0%, respectively. More specifically, the weight ratio of the tea tree leaf: mugwort: buckwheat: capryloyl salicylic acid may be 33.334: 33.334: 33.331: 0.001.

본 발명에 따른 티트리잎, 쑥, 메밀, 카프릴로일살리실릭애씨드를 유효성분으로 함유하는 항산화, 항염, 피부진정, 재생, 탄력 및 보습효과를 지닌 화장료 조성물에서, 상기 혼합추출물은 최종 형태 중에 적어도 0.01 내지 30.0 중량%로 함유하고, 보다 바람직하게는 0.1 내지 20.0 중량%로 함유하며, 보다 바람직하게는 1.0 내지 10.0중량%로 함유한다.In the cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects containing tea tree leaf, mugwort, buckwheat, and capryloyl salicylic acid as active ingredients according to the present invention, the mixed extract is in the final form It contains at least 0.01 to 30.0% by weight, more preferably 0.1 to 20.0% by weight, and more preferably 1.0 to 10.0% by weight.

상기 혼합추출물의 함량 0.001 중량% 미만일 경우에는 항산화효과가 나타나지 않으며, 30 중량% 이상으로 함유시에는 그 효과가 크게 증가하지 않으며, 제형상의 안전성과 안정성에 문제가 발생되어 경제성도 대체적으로 낮아진다.When the content of the mixed extract is less than 0.001% by weight, the antioxidant effect does not appear, and when it contains more than 30% by weight, the effect does not significantly increase, and the safety and stability of the formulation are problematic and economical efficiency is generally lowered.

본 발명에 의한 항산화 화장료 조성물은 피부에 대한 과학적인 기초자료에 근거한 조합으로 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 각각 혼합하여 추출한 혼합추출물을 유효성분으로 사용할 경우 항산화, 항염, 피부진정, 재생, 탄력 및 보습효과 측면에서 실질적으로 장기적인 효능을 구현할 수 있다.The antioxidant cosmetic composition according to the present invention is a combination based on scientific basic data on skin. When using a mixed extract extracted by mixing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid as an active ingredient, antioxidant, anti-inflammatory, In terms of skin soothing, regeneration, elasticity, and moisturizing effects, it is possible to implement practically long-term efficacy.

본 발명의 화장료 조성물에 포함되는 성분은 상기의 본 발명에 따른 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 각각 혼합하여 추출한 혼합물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료, 색소 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The ingredients included in the cosmetic composition of the present invention include ingredients commonly used in cosmetic compositions in addition to the mixture extracted by mixing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid according to the present invention, for example, and conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments, pigments and fragrances, and carriers.

본 발명의 화장료 조성물은 당 업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양크림, 맛사지 크림, 에센스, 팩, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다. The cosmetic composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing , oil, powder foundation, emulsion foundation, wax foundation, spray, etc., but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, a nourishing lotion, a nourishing cream, a massage cream, an essence, a pack, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray, or a powder.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, any one or more of animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide as a carrier component can be used by selecting .

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane /may contain propellants such as butane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 부틸렌글리콜, 1,3-부틸글리콜 오일, 폴리옥시에칠렌 경화피마자유, 글리세롤, 글리세린, 지방족 에스테르, 페녹시에탄올, 트리에탄올아민, 폴리에틸렌 글리콜, 밀납, 폴리솔베이트 60, 솔비탄세스퀴오레이드, 파라핀, 소르비탄 스테아레이트, 친유형 모노스테아린산 글리세린, 스테아린산, 글리세릴스테아레이트/피이지-400 스테아레이트, 카르복시폴리머, 시토스테롤, 폴리글리세릴 2-올레이트, 세라마이드, 콜레스테롤, 스테아레스-4, 디세틸포스페이트, 마카다미아 오일, 카르복시비닐폴리머, 산탄검 또는 소르비탄의 지방산 에스테르 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, butyl Renglycol, 1,3-butyl glycol oil, polyoxyethylene hydrogenated castor oil, glycerol, glycerin, aliphatic ester, phenoxyethanol, triethanolamine, polyethylene glycol, beeswax, polysorbate 60, sorbitan sesquioleate, paraffin, Sorbitan stearate, lipophilic monostearic acid glycerin, stearic acid, glyceryl stearate/PEG-400 stearate, carboxypolymer, sitosterol, polyglyceryl 2-oleate, ceramide, cholesterol, stearate-4, dicetylphosphate , macadamia oil, carboxyvinyl polymer, xanthan gum, or fatty acid ester of sorbitan may be selected and used.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올, 글리세린, 부틸렌글리콜 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 하이드록시에틸셀룰로오즈, 소디움히아루로네이트, 페녹시에탄올, 알루미늄 메타히드록시드, 벤토나이트, 스테아린산, 세틸알코올, 글리세릴모노스테아레이트, 폴리옥시에틸렌소르비탄모노스테아레이트, 솔비탄세스퀴올레이트, 글리세릴모노스테아레이트/글리세릴스테아레이트/폴리옥시에틸렌스테아레이트, 왁스, 파리핀, 스쿠알란, 카프릴릭/카프릭트리글리세라이드, 카르복시비닐폴리머, 트리에탄올아민, 아가 또는 트라칸트 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, water, a liquid diluent such as ethanol, glycerin, butylene glycol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester; Suspending agents such as microcrystalline cellulose, hydroxyethyl cellulose, sodium hyaluronate, phenoxyethanol, aluminum metahydroxide, bentonite, stearic acid, cetyl alcohol, glyceryl monostearate, polyoxyethylene sorbitan monostearate , sorbitan sesquioleate, glyceryl monostearate/glyceryl stearate/polyoxyethylene stearate, wax, paraffin, squalane, caprylic/capric triglyceride, carboxyvinyl polymer, triethanolamine, agar or triglyceride Any one or more of Kant may be selected and used.

본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide as carrier components Any one or more of ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester may be selected and used.

또한, 본 발명의 일 실시예에 따른 화장료 조성물의 사용효능은 개인의 피부상태와 컨디션, 외부 환경 조건에 따라 알맞게 조절이 가능하다.In addition, the efficacy of the cosmetic composition according to an embodiment of the present invention can be appropriately adjusted according to the individual's skin condition and condition, and external environmental conditions.

이하, 본 발명의 이해를 돕기 위해 실시예 및 실험예를 제시하여 상세하게 설명하기로 한다. 그러나, 하기의 실시예 및 실험예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 이에 의해 본 발명의 기술적 수준과 범위가 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예 및 실험예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되는 것이다.Hereinafter, to help the understanding of the present invention will be described in detail by presenting examples and experimental examples. However, the following examples and experimental examples are only provided for easier understanding of the present invention, and should not be construed as limiting the technical level and scope of the present invention thereby. The Examples and Experimental Examples of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art.

< < 실시예Example 1 > 1 > 티트리잎tea tree leaves , 쑥, 메밀 및 , mugwort, buckwheat and 카프릴로일살리실릭애씨드Capryloyl Salicylic Acid 혼합추출물의 제조 Preparation of mixed extract

티트리잎, 쑥, 메밀을 정제수에 각각 세척하여 건조한 다음 분쇄하여 티트리잎, 쑥, 메밀 : 카프릴로일살리실릭애씨드를 33.334 : 33.334 : 33.331 : 0.001의 비율로 혼합하여 혼합 분쇄물 50 g/L가 되도록 30% 에탄올에 수용액 1 kg을 첨가하고, 60 ~ 90℃ 조건에서 4시간씩 3회 환류추출하고 실온으로 냉침한 후, 와트만(whatman) #3 여과지로 여과하여 50℃ 이하에서 감압농축 및 동결 건조하여 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 제조하였다.Wash and dry each tea tree leaf, mugwort, and buckwheat in purified water, then pulverize the tea tree leaf, mugwort, and buckwheat: capryloyl salicylic acid in a ratio of 33.334: 33.334: 33.331: 0.001 to mix and pulverize 50 g/ Add 1 kg of aqueous solution to 30% ethanol so as to become L, and extract under reflux 3 times for 4 hours at 60 ~ 90 ° C., cooled to room temperature, filtered with Whatman #3 filter paper, and reduced pressure at 50 ° C. or less Concentrated and freeze-dried to prepare a mixed extract of tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid.

< < 실시예Example 2 > 2 > 티트리잎tea tree leaves , 쑥 및 , mugwort and 카프릴로일살리실릭애씨드Capryloyl Salicylic Acid 혼합추출물의 제조 Preparation of mixed extract

티트리잎, 쑥을 정제수에 각각 세척하여 건조한 다음 분쇄하여 티트리잎, 쑥 및 : 카프릴로일살리실릭애씨드를 49.9995 : 49.995 : 0.001의 비율로 혼합하여 혼합 분쇄물 50 g/L가 되도록 30% 에탄올에 수용액 1 kg을 첨가하고, 60 ~ 90℃ 조건에서 4시간씩 3회 환류추출하고 실온으로 냉침한 후, 와트만(whatman) #3 여과지로 여과하여 50℃ 이하에서 감압농축 및 동결 건조하여 티트리잎, 쑥 및 카프릴로일살리실릭애씨드 혼합추출물을 제조하였다.Wash and dry each tea tree leaf and mugwort in purified water, then grind and mix tea tree leaf, mugwort and: capryloyl salicylic acid in a ratio of 49.9995: 49.995: 0.001 to make a mixed pulverized product of 50 g/L 30% 1 kg of aqueous solution was added to ethanol, refluxed and extracted 3 times for 4 hours at 60 ~ 90 ° C., cooled to room temperature, filtered with Whatman #3 filter paper, concentrated under reduced pressure at 50 ° C. or less, and freeze-dried. A mixed extract of tea tree leaf, mugwort and capryloyl salicylic acid was prepared.

< < 실시예Example 3 > 3 > 티트리잎tea tree leaves , 메밀 및 , buckwheat and 카프릴로일살리실릭애씨드Capryloyl Salicylic Acid 혼합추출물의 제조 Preparation of mixed extract

티트리잎, 메밀을 정제수에 각각 세척하여 건조한 다음 분쇄하여 티트리잎, 메밀 및 : 카프릴로일살리실릭애씨드를 49.9995 : 49.995 : 0.001의 비율로 혼합하여 혼합 분쇄물 50 g/L가 되도록 30% 에탄올에 수용액 1 kg을 첨가하고, 60 ~ 90℃ 조건에서 4시간씩 3회 환류추출하고 실온으로 냉침한 후, 와트만(whatman) #3 여과지로 여과하여 50℃ 이하에서 감압농축 및 동결 건조하여 티트리잎, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 제조하였다.Wash and dry each tea tree leaf and buckwheat in purified water, then pulverize the tea tree leaf, buckwheat and : capryloyl salicylic acid in a ratio of 49.9995 : 49.995 : 0.001 to make a mixed pulverized product of 50 g/L 30% 1 kg of aqueous solution was added to ethanol, refluxed and extracted 3 times for 4 hours at 60 ~ 90 ° C., cooled to room temperature, filtered with Whatman #3 filter paper, concentrated under reduced pressure at 50 ° C. or less, and freeze-dried. A mixed extract of tea tree leaf, buckwheat and capryloyl salicylic acid was prepared.

< 실시예 4 > 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물의 제조<Example 4> Preparation of mixed extract of mugwort, buckwheat and capryloyl salicylic acid

쑥, 메밀을 정제수에 각각 세척하여 건조한 다음 분쇄하여 쑥, 메밀 및 : 카프릴로일살리실릭애씨드를 49.9995 : 49.995 : 0.001의 비율로 혼합하여 혼합 분쇄물 50 g/L가 되도록 30% 에탄올에 수용액 1 kg을 첨가하고, 60 ~ 90℃ 조건에서 4시간씩 3회 환류추출하고 실온으로 냉침한 후, 와트만(whatman) #3 여과지로 여과하여 50℃ 이하에서 감압농축 및 동결 건조하여 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 제조하였다.Mugwort and buckwheat are washed in purified water, dried, and then pulverized. Mugwort, buckwheat and: capryloyl salicylic acid are mixed in a ratio of 49.9995: 49.995: 0.001 to obtain 50 g/L of the mixed pulverized product, 1 aqueous solution in 30% ethanol. kg, extracted under reflux 3 times for 4 hours at 60 ~ 90℃ conditions, cooled to room temperature, filtered with Whatman #3 filter paper, concentrated under reduced pressure at 50℃ or less, and freeze-dried to produce mugwort, buckwheat and A mixed extract of capryloyl salicylic acid was prepared.

< < 제조예production example and 비교예comparative example > > 피부진정skin soothing , 재생, 탄력 및 , regenerating, resilient and 보습효과를moisturizing effect 지닌 유효성분 조성분 제조 Manufacture of active ingredients with

피부진정, 재생, 탄력 및 보습효과 능력을 평가하기 위하여 본 발명의 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합물과 종래 보습제로 알려진 글리세린(LG 생활건강), 히알루론산(상동 하비어 바이오파마)을 표 1과 같이 각각 제조하여 실험을 진행하였다.In order to evaluate the skin soothing, regeneration, elasticity and moisturizing effect ability, the tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixture of the present invention, glycerin (LG Household & Health Care), hyaluronic acid (same as Hobby Bio) known as conventional moisturizers Perm) was prepared as shown in Table 1, respectively, and the experiment was carried out.

성분명Ingredient name 시료명Sample name 제조예1Preparation Example 1 제조예2Preparation Example 2 제조예3Preparation 3 제조예4Preparation 4 비교예1Comparative Example 1 비교예2Comparative Example 2 AA 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물의 제조Preparation of tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract 2.02.0 티트리잎, 쑥 및 카프릴로일살리실릭애씨드 혼합추출물의 제조Preparation of tea tree leaf, mugwort and capryloyl salicylic acid mixed extract 2.02.0 티트리잎, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물의 제조Preparation of tea tree leaf, buckwheat and capryloyl salicylic acid mixed extract 2.02.0 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물의 제조Preparation of Mugwort, Buckwheat and Capryloyl Salicylic Acid Mixed Extract 2.02.0 글리세린glycerin 2.02.0 히알루론산(0.5%)Hyaluronic acid (0.5%) 2.02.0 EDTA-2NAEDTA-2NA 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 정제수Purified water To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 BB 메틸글루코오스세스퀴스테아레이트Methylglucose sesquistearate 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 글리세릴스테아레이트Glyceryl Stearate 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 폴리솔베이트60Polysorbate 60 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 세틸알코올cetyl alcohol 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 1.51.5 비즈왁스beeswax 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 0.50.5 카프릴릭/카프릭트라이글리세라이드Caprylic/Capric Triglycerides 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 시어버터shea butter 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 다이메티콘dimethicone 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 토코페릴아세테이트tocopheryl acetate 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 0.30.3 향, 방부제fragrance, preservative 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount 미량a very small amount

< < 시험예test example 1 > 세포생존율 시험 1 > Cell viability test

1) 실험방법1) Experimental method

상기 실시예 1 내지 4에서 제조된 시료에 대하여 세포 증식에 미치는 영향을 확인하였다. 세포 증식 및 독성 확인을 위하여 하기와 같은 방법으로 실험을 진행하였다.For the samples prepared in Examples 1 to 4, the effect on cell proliferation was confirmed. In order to confirm cell proliferation and toxicity, the experiment was carried out in the following manner.

배양하고 있는 세포 3T3(fibroblast cell line)을 96 웰 마이크로플레이트에 5,000 세포/ml로 분주(分株)하여 30분간 항온조에서 배양하고, 시료를 농도별 각각 0.0, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0(%, V/V))로 투여하여 72시간 동안 배양하였다.Cells in culture 3T3 (fibroblast cell line) were dispensed in a 96-well microplate at 5,000 cells/ml, incubated in a thermostat for 30 minutes, and samples were incubated at each concentration of 0.0, 0.5, 1.0, 2.0, 3.0, 4.0. , 5.0 (%, V/V)) and cultured for 72 hours.

72시간 배양 후, 티아졸린 블루(Thiazoline blue)를 투여하고 4시간 동안 추가 배양을 하였다. 배양액을 모두 버리고 마이크로플레이트의 각 웰에 반응 정지액을 가하고 5분간 교반한 후, 570㎚에서 흡광도를 측정하였다. 대조군은 시료 주입량만큼10% 우태아혈청(Fetal Bovine Ser㎛, FBS) 배지를 투여하여 세포 성장의 최적 조건으로 동시배양을 하였으며, 대조군의 세포증식을 100 %로 하고 시료 투입 실험군의세포 증식율을 계산하였다.After 72 hours of incubation, Thiazoline blue was administered and further cultured for 4 hours. After discarding all of the culture solution, a reaction stop solution was added to each well of the microplate, stirred for 5 minutes, and absorbance was measured at 570 nm. The control group was co-cultured under optimal conditions for cell growth by administering 10% Fetal Bovine Serum (FBS) medium as much as the sample injection amount. did

세포증식 효과는 하기 계산식 1에 의해 산출되었고, 그 결과는 하기 표 2에 나타내었다.The cell proliferation effect was calculated by Equation 1 below, and the results are shown in Table 2 below.

Figure 112021063716268-pat00001
Figure 112021063716268-pat00001

2) 실험결과2) Experiment result

시료명Sample name 시료 처리농도별(%) 세포 생존율(%)Cell viability (%) by sample treatment concentration (%) 00 0.50.5 1.01.0 2.02.0 3.03.0 4.04.0 5.05.0 실시예1Example 1 100100 101.5101.5 102.2102.2 101.9101.9 101.6101.6 100.5100.5 99.899.8 실시예2Example 2 100100 101.1101.1 101.9101.9 102.3102.3 102.1102.1 101.3101.3 100.1100.1 실시예3Example 3 100100 101.2101.2 100.8100.8 100.7100.7 100.2100.2 99.899.8 98.798.7 실시예4Example 4 100100 101.1101.1 100.8100.8 100.3100.3 99.499.4 98.998.9 97.497.4

상기 표 2에 나타낸 봐와 같이, 실기예 1 내지 4와 같이 제조된 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 혼합추출한 시료 모두에서 독성이 없는 것으로 확인하였다. As shown in Table 2, it was confirmed that none of the samples obtained by mixing extraction of tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid prepared as in Examples 1 to 4 were toxic.

< 시험예 2 > 자유라디칼 소거 효과 확인 <Test Example 2> Confirmation of free radical scavenging effect

1) 실험방법1) Experimental method

상기 실시예 1 내지 4에서 제조된 시료에 대하여 자유라디칼(Free Radical) 소거에 미치는 영향을 확인하였다. 자유라디칼(Free Radical) 소거에 미치는 영향을 확인하기 위하여 하기와 같은 방법으로 실험을 진행하였다.For the samples prepared in Examples 1 to 4, the effect on free radical scavenging was confirmed. In order to confirm the effect on free radical scavenging, the experiment was conducted as follows.

DPPH(1,1-디페닐-2피크릴-히드라질)법 (참조:Blois.M.S.Nature 181, 1190, 1958)을 사용하여 실험을 수행하였으며, DPPH와 Quercetin은 시그마(SIGMA)사의 것을 사용하였다. 0.2 mM DPPH 메탄올 용액 1 ml에 여러 농도(0.5, 1.0, 2.0, 3.0, 4.0, 5.0 %)의 실시예 1 내지 4와 양성대조군을 각각 2 ml씩 첨가하고 교반한 후 실온에서 10분간 반응시켰다. 그 후, 517 nm에서 흡광도를 측정하였으며, 이때 공시험으로 각 시료 대신 정제수를 사용하였다.Experiments were performed using the DPPH (1,1-diphenyl-2 picryl-hydrazyl) method (refer to: Blois. MSNature 181, 1190, 1958), DPPH and Quercetin were SIGMA's. . 2 ml each of Examples 1 to 4 and positive control of various concentrations (0.5, 1.0, 2.0, 3.0, 4.0, 5.0%) were added to 1 ml of 0.2 mM DPPH methanol solution, stirred, and reacted at room temperature for 10 minutes. Then, absorbance was measured at 517 nm, and purified water was used instead of each sample as a blank test.

하기 계산식 2를 이용하여 자유라디칼의 변화를 측정하였고 그 결과를 표 2에 나타내었다.The change of free radicals was measured using Equation 2 below, and the results are shown in Table 2.

Figure 112021063716268-pat00002
Figure 112021063716268-pat00002

2) 실험결과2) Experiment result

자유라디칼 소거에 대한 결과는 하기 표 2에 나타내었다. The results for free radical scavenging are shown in Table 2 below.

시료명Sample name 시료 처리농도별(%) 라디칼소거 효과 (%)By sample treatment concentration (%) Radical scavenging effect (%) 0.010.01 0.50.5 1.01.0 2.02.0 3.03.0 4.04.0 5.05.0 대조군control 90.490.4 실시예1Example 1 28.328.3 45.045.0 55.655.6 67.567.5 73.673.6 76.276.2 실시예2Example 2 21.521.5 36.136.1 47.247.2 59.659.6 65.365.3 67.867.8 실시예3Example 3 20.920.9 34.834.8 45.145.1 56.756.7 64.864.8 66.766.7 실시예4Example 4 16.616.6 29.329.3 40.340.3 53.453.4 59.959.9 61.861.8

상기 표 3에 나타낸 바와 같이, 실시예 1 내지 4 모두 자유라디칼 소거에 효과적인 것을 확인할 수 있었다. 특히, 실시예 1의 경우 실시예 2 내지 4에 비해 항산화 효과가 월등하게 높은 것을 확인할 수 있었다. As shown in Table 3, it was confirmed that all of Examples 1 to 4 were effective in scavenging free radicals. In particular, in the case of Example 1, it was confirmed that the antioxidant effect was significantly higher than that of Examples 2 to 4.

< 시험예 3 > NO 생성 억제에 의한 항염증 효과조사<Test Example 3> Anti-inflammatory effect investigation by inhibition of NO production

1) 실험방법1) Experimental method

마우스 대식세포인 Raw 264.7 세포를 6-웰플레이트에 3.5 Х 105세포/ml 농도로 분주하여 24시간 배양시켰다. 그 이후, 각 웰에 실시예 1 내지 4에서 제조한 시료를 희석하여 함유한 세포배지로 교체하였다. 자극원으로 LPS(Lipopolysaccharide)를 1 ㎍씩 처리하여 24시간 동안 배양하였다. 상층액을 100 ㎕씩 취해 96-웰 플레이트에 옮기고, Griess 용액을 100 ㎕씩 가해 상온에서 10분간 반응시키고, 540 nm에서의 흡광도를 측정함으로써 NO 억제효과를 판단하고, 그 결과를 하기 표 4에 나타내었다.Raw 264.7 cells, which are mouse macrophages, were dispensed in a 6-well plate at a concentration of 3.5 Х 10 5 cells/ml and cultured for 24 hours. After that, each well was replaced with a cell medium containing diluted samples prepared in Examples 1 to 4. 1 μg of LPS (Lipopolysaccharide) was treated as a stimulus and cultured for 24 hours. 100 μl of the supernatant was taken and transferred to a 96-well plate, 100 μl of Griess solution was added and reacted at room temperature for 10 minutes, and the NO inhibitory effect was determined by measuring the absorbance at 540 nm, and the results are shown in Table 4 below. indicated.

시료명Sample name 시료 처리농도별(%) NO 생성 저해율(%)By sample treatment concentration (%) NO production inhibition rate (%) 0.00.0 0.50.5 1.01.0 2.02.0 3.03.0 4.04.0 5.05.0 LPSLPS ++ ++ ++ ++ ++ ++ ++ 실시예1Example 1 0.00.0 6.676.67 15.8315.83 20.8320.83 27.5027.50 34.1734.17 37.5037.50 실시예2Example 2 0.00.0 3.333.33 10.8310.83 17.5017.50 23.3323.33 27.5027.50 29.1729.17 실시예3Example 3 0.00.0 0.830.83 9.179.17 13.3313.33 18.3318.33 24.1724.17 27.5027.50 실시예4Example 4 0.00.0 1.671.67 7.507.50 11.6711.67 16.6716.67 23.3323.33 25.8325.83

표 4와 같이 실시예 1 내지 4 모두 농도 의존적으로 NO 생성을 억제하는 효능을 지니고 있는 것을 확인하였다. 특히, 실시예 1의 경우 상기 실험예 2 내지 4와 비교시 NO 생성 저해율이 우수한 것으로 확인되었다.As shown in Table 4, it was confirmed that all of Examples 1 to 4 have the effect of inhibiting NO production in a concentration-dependent manner. In particular, in the case of Example 1, it was confirmed that the NO production inhibition rate was excellent as compared to Experimental Examples 2 to 4.

< 시험예 4 ><Test Example 4> 피부자극물질에 대한 진정효과 Soothing effect on skin irritants

피부질환이나 알러지 증상이 없으며 과민반응 이력이 없는 20 ~ 50대 건강한 성인남녀 20명을 대상을 인체피부첩보실험을 통하여 피부 진정 효과를 확인하였다.The skin soothing effect was confirmed through the human skin intelligence test on 20 healthy adult men and women in their 20s and 50s who had no skin disease or allergy symptoms and had no history of hypersensitivity reactions.

상기 제조예 1 내지 4 및 비교예 1 내지 2의 화장료와 대조시료에 피부자극물질인 락틱산 5%를 첨가하여 각각에 대하여 피부첩포 시험을 실시하였다. 진정시험 진행에 앞서 시험대상자의 전완 안쪽부위에 70% 에탄올로 충분히 닦아낸 후 완전히 건조하여 9종의 화장료를 각 30 ㎍씩 첩포하였다. 첩포 시간을 기준으로 24시간이 경과한 후 패치를 제거하고 약 30분 후 확대경(MicroView)으로 첩포 부위를 관찰하여 홍반 및 부종 유무를 확인하였다. 평가는 하기 표 5의 기준으로 시행하였으며, 하기 수학식 3에 따라 평균피부 반응도를 계산하였다. 그 결과는 하기 표 6에 나타내었다.To the cosmetics and control samples of Preparation Examples 1 to 4 and Comparative Examples 1 to 2, 5% of lactic acid, a skin irritant, was added, and a skin patch test was performed for each. Before proceeding with the sedation test, the inner part of the subject's forearm was thoroughly wiped with 70% ethanol, dried completely, and 30 ㎍ each of 9 cosmetics was applied. After 24 hours had elapsed based on the application time, the patch was removed, and after about 30 minutes, the patch site was observed with a magnifying glass (MicroView) to check for erythema and edema. The evaluation was performed based on the criteria of Table 5 below, and the average skin reactivity was calculated according to Equation 3 below. The results are shown in Table 6 below.

기호sign 점수score 피부반응skin reaction 평가기준Evaluation standard -- 00 무자극non-irritant 무반응no response ±± 0.50.5 미자극unstimulated 희미한 또는 가까스로 감지할 수 있는 가벼운 홍반Faint or barely detectable mild erythema ++ 1One 경자극mild stimulation 경계가 뚜렷하나 약한 홍반Demarcated but mild erythema ++++ 22 중자극central stimulus 뚜렷한 홍반distinct erythema ++++++ 33 강자극strong stimulus 심한 홍반 및 대 수포Severe erythema and blistering

Figure 112021063716268-pat00003
Figure 112021063716268-pat00003

2) 실험결과)2) Experiment result)

피부 진정 효과에 대한 결과는 하기 표 6에 나타내었다.The results for the skin soothing effect are shown in Table 6 below.

시료명Sample name 점수score 반응도reactivity 00 0.50.5 1.01.0 2.02.0 3.03.0 제조예1Preparation Example 1 -- 33 -- -- -- 2.52.5 제조예2Preparation Example 2 -- 44 -- -- -- 3.33.3 제조예3Preparation 3 -- 55 -- -- -- 4.24.2 제조예4Preparation 4 -- 44 -- -- -- 3.33.3 비교예1Comparative Example 1 -- 1010 1One -- -- 10.010.0 비교예2Comparative Example 2 -- 1111 22 -- -- 12.512.5 대조시료control sample -- 1414 33 -- -- 16.716.7

상기 표 6의 결과 제조예 1 내지 4는 대조시료와 비교시 락틴산을 통해 유도된 자극에 대해 피부진정 효과가 우수한 것으로 확인된 반면, 비교예 1 내지 2의 경우에 의해 유도된 자극에 대해 대조시료와 큰 차이가 없는 것을 확인할 수 있었다.As a result of Table 6, Preparation Examples 1 to 4 were confirmed to have excellent skin soothing effects for stimulation induced through lactic acid when compared to control samples, whereas Comparative Examples 1 to 2 were compared for stimulation induced by the case It was confirmed that there was no significant difference from the sample.

또한, 제조예 1과 2 내지 4를 비교하면 티트리잎, 쑥, 메밀, 카프릴로일살리실릭애씨드를 혼합한 제조예 1에서 시너지효과가 가장 우수한 것으로 확인할 수 있었다. In addition, comparing Preparation Examples 1 and 2 to 4, it was confirmed that the synergistic effect was the most excellent in Preparation Example 1, in which tea tree leaf, mugwort, buckwheat, and capryloyl salicylic acid were mixed.

< 시험예 5 > 세포재생 능력측정<Test Example 5> Cell regeneration ability measurement

1) 실험방법1) Experimental method

HACAT 각질형성세포를 24-웰플레이트에 1.0 Х 105세포/ml의 농도로 분주 하여 24시간 배양시킨 후, 200 ㎕ 파이펫 팁으로 세포를 긁어내었다. 그 후, 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물 2%를 상기 웰플레이트에 첨가하고 72시간 동안 배양하여 세포의 이동 정도를 측정하였다. 대조군으로 EFG를 이용하여 세포이동 능력을 확인하였다. HACAT keratinocytes were dispensed in a 24-well plate at a concentration of 1.0 Х 10 5 cells/ml and cultured for 24 hours, and then the cells were scraped off with a 200 μl pipette tip. Then, tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract 2% was added to the well plate and cultured for 72 hours to measure the degree of cell migration. Cell migration ability was confirmed using EFG as a control.

2) 실험결과)2) Experiment result)

실험결과는 표 7과 같이 세포재생효과를 확인하였다.The experimental results confirmed the cell regeneration effect as shown in Table 7.

시간hour 대조군(EGF)Control (EGF) 실시예1Example 1 실시예2Example 2 실시예3Example 3 실시예4Example 4

0


0

Figure 112021063716268-pat00004
Figure 112021063716268-pat00004
Figure 112021063716268-pat00005
Figure 112021063716268-pat00005
Figure 112021063716268-pat00006
Figure 112021063716268-pat00006
Figure 112021063716268-pat00007
Figure 112021063716268-pat00007
Figure 112021063716268-pat00008
Figure 112021063716268-pat00008


72


72
Figure 112021063716268-pat00009
Figure 112021063716268-pat00009
Figure 112021063716268-pat00010
Figure 112021063716268-pat00010
Figure 112021063716268-pat00011
Figure 112021063716268-pat00011
Figure 112021063716268-pat00012
Figure 112021063716268-pat00012
Figure 112021063716268-pat00013
Figure 112021063716268-pat00013

표 7과 같이 실시예 1 내지 4 모두 2%의 시료농도에서 세포이동을 통한 재생능력을 확인할 수 있었다. 특히, 실시예 1의 경우 대조군인 EGF의 수준을 세포재생능력을 나타냄에 따라 실시예 2 내지 4보다 우수한 재생능력을 지님을 확인할 수 있었다. As shown in Table 7, in all of Examples 1 to 4, regeneration ability through cell migration was confirmed at a sample concentration of 2%. In particular, in the case of Example 1, it was confirmed that the level of EGF, which is a control, showed cell regeneration ability, and thus had superior regeneration ability than Examples 2 to 4.

< 시험예 6 ><Test Example 6> 피부보습 효과skin moisturizing effect

상기 표 1의 제조예 및 비교예에서 제조한 화장료를 피시험자(25세-50세)의 남성 및 여성) 20명을 대상으로 1일 2회씩 4주간 안면 양쪽의 얼굴 및 전반부에 제조예 1 내지 4 및 비교예 1 내지 2의 화장품 제형을 각각 도포하여 도포하기 전, 2주 경과 후, 그리고 4주경과 후의 피부보습 개선상태를 피부수분측정기 Corneometer CM 820 (Courage + Khazaka, Germany)를 이용하여 측정하였으며, 단위는 기기에서 부여하는 임의의 단위(Arbitrary Unit, AU)로 표현되며, 측정값이 높을수록 피부표면에 수분량이 높음을 의미한다.The cosmetics prepared in Preparation Examples and Comparative Examples of Table 1 were applied to 20 subjects (male and female of 25-50 years of age) twice a day for 4 weeks on both sides of the face and in the first half of Preparation Examples 1 to The cosmetic formulations of 4 and Comparative Examples 1 and 2 were respectively applied and the skin moisture improvement status was measured before, after 2 weeks, and after 4 weeks using a skin moisture meter Corneometer CM 820 (Courage + Khazaka, Germany). The unit is expressed as an arbitrary unit (Arbitrary Unit, AU) given by the device, and the higher the measured value, the higher the moisture content on the skin surface.

2) 실험결과2) Experiment result

피부보습 개선에 관한 실험 결과는 하기 표 8에 나타내었다.The experimental results on skin moisture improvement are shown in Table 8 below.

시료명Sample name 피부보습 효과(AU)Skin moisturizing effect (AU) 도포 전before application 2주 후2 weeks later 4주 후after 4 weeks 제조예 1Preparation Example 1 54.654.6 59.859.8 68.868.8 제조예 2Preparation 2 53.753.7 58.858.8 66.966.9 제조예 3Preparation 3 54.454.4 58.758.7 66.366.3 제조예 4Preparation 4 53.953.9 58.458.4 65.965.9 비교예 1Comparative Example 1 55.155.1 54.954.9 55.355.3 비교예 2Comparative Example 2 54.754.7 54.854.8 55.155.1

상기 표 8에 나타난 바와 같이 제조예 1 내지 4 및 비교예 1 내지 2에 따라 제조된 화장료 조성물에 대하여 보습효과를 측정하였으며, 그 결과 제조예 1 내지 4에서 비교예 1 내지 2보다 보습력이 높아진 것을 확인할 수 있었다. 특히, 제조예 1의 경우 제조예 2 내지 4보다 보습 효과가 더 우수하게 상승하는 것을 확인할 수 있었다. As shown in Table 8, the moisturizing effect was measured for the cosmetic compositions prepared according to Preparation Examples 1 to 4 and Comparative Examples 1 to 2, and as a result, the moisturizing effect was higher in Preparation Examples 1 to 4 than Comparative Examples 1 to 2 could check In particular, in the case of Preparation Example 1, it was confirmed that the moisturizing effect was more excellently increased than in Preparation Examples 2 to 4.

< < 시험예test example 7 > 7 > 경피수분손실량transdermal water loss 확인 Confirm

1) 실험방법1) Experimental method

표 1의 제조예 1 내지 7, 비교예 1 내지 2의 화장료 조성물을 각각 피시험자(20 ~ 50대 남성 및 여성) 20명을 대상으로 상박 부위를 측정부위로 설정하여 가로, 세로 2 Х 2 cm2의 크기로 시험부위를 표시한 후 측정하였다. 시험부위에 화장료 조성물을 도포한 후 잘 문지르고, TEWAMETER TM210(C+K eletronic GmhH. Germany)을 이용하여 경피수분손실량을 측정하였다. 도포하기 전 0시간의 수분 보유량을 기준으로 도포 후 30분, 도포 후 4일, 8일 후의 수분증가율(%)을 측정하여 단기보습효과를 평가하였다. 측정시 probe를 수직으로 접촉하여 60초 동안 수평을 유지하면서 3회 연속적으로 경피수분손실량을 측정하였다. 측정은 항온 항습실에서 동일하게 진행하였으며, 수치가 높을수록 수분의 손실이 많음을 의미한다.For each of the cosmetic compositions of Preparation Examples 1 to 7 and Comparative Examples 1 and 2 in Table 1, 20 subjects (male and female in their 20s to 50s) set the upper arm as the measurement site, and set the width and length 2 Х 2 cm After marking the test site with a size of 2, measurements were made. After applying the cosmetic composition to the test site, it was rubbed well, and the amount of transdermal moisture loss was measured using TEWAMETER TM210 (C+K eletronic GmhH. Germany). Short-term moisturizing effect was evaluated by measuring the moisture increase rate (%) 30 minutes after application, 4 days after application, and 8 days after application, based on the water retention amount of 0 hours before application. During the measurement, the amount of transdermal water loss was measured three times consecutively while keeping the probe vertical for 60 seconds. Measurements were carried out in the same temperature and humidity room, and the higher the value, the greater the loss of moisture.

2) 실험결과2) Experiment result

경피수분손실량에 대한 피부보습결과는 하기 표 9에 나타내었다.The skin moisturizing results for the amount of percutaneous moisture loss are shown in Table 9 below.

시료명Sample name 수분손실량(%)Water loss (%) 도포 후 30분30 minutes after application 도포 후 1일1 day after application 도포 후 4일4 days after application 도포 후 8일8 days after application 제조예1Preparation Example 1 26.526.5 25.325.3 22.722.7 19.619.6 제조예2Preparation Example 2 26.826.8 25.925.9 23.923.9 21.821.8 제조예3Preparation 3 27.127.1 26.326.3 24.424.4 22.322.3 제조예4Preparation 4 27.227.2 26.526.5 24.624.6 22.822.8 비교예1Comparative Example 1 34.534.5 34.334.3 33.933.9 33.433.4 비교예2Comparative Example 2 37.237.2 37.037.0 36.636.6 36.336.3

표 9에 나타난 바와 같이 8일간 제조예 1 내지 4 및 비교예 1 내지 2의 경피수분손실량을 비교한 결과 제조예 1 내지 4에서 비교예 1 및 2보다 수분손실량이 감소되는 것을 확인할 수 있었다. 특히, 제조예 1은 제조예 2 내지 4보다 손실량 개선이 가장 높은 것을 확인할 수 있었다. As shown in Table 9, as a result of comparing the amount of transdermal water loss in Preparation Examples 1 to 4 and Comparative Examples 1 to 2 for 8 days, it was confirmed that the amount of water loss was reduced in Preparation Examples 1 to 4 compared to Comparative Examples 1 and 2. In particular, it was confirmed that Preparation Example 1 had the highest loss amount improvement than Preparation Examples 2 to 4.

<시험예 8> 피부탄력개선효과 확인<Test Example 8> Confirmation of skin elasticity improvement effect

상기 제조예 1 내지 4 및 비교예 1 내지 2에서 제조한 시료를 사람을 대상으로 피부탄력개선효과 실험을 행하여 피부 탄력 개선 효과를 평가하였다.The skin elasticity improvement effect was evaluated by performing a skin elasticity improvement effect test on the samples prepared in Preparation Examples 1 to 4 and Comparative Examples 1 to 2 on humans.

비교실험에 사용된 화장료는 제조예 1 내지 4 및 비교예 1 내지 2에서 제조한 시료이다. 실험자(20세-35세의 여성) 20명을 대상으로 얼굴의 각 부위별로 제조예 1 내지 4 및 비교예 1 내지 2에서 제조한 시료를 각각 1일 2회씩 연속 2개월간 도포하였다.The cosmetics used in the comparative experiment were samples prepared in Preparation Examples 1 to 4 and Comparative Examples 1 to 2. The samples prepared in Preparation Examples 1 to 4 and Comparative Examples 1 to 2 were applied to 20 experimenters (females aged 20-35 years) for each part of the face twice a day for 2 consecutive months.

실험완료 후 피부 탄력 개선 효과는 제품 사용 전과 2개월간 사용 후에 피부탄력측정기(cutometer SEM 575, C+K Electronic Co., Germany)를 이용하여 측정하였다.After completion of the experiment, the skin elasticity improvement effect was measured using a skin elasticity meter (cutometer SEM 575, C+K Electronic Co., Germany) before and after using the product for 2 months.

실험결과는 하기 표 10에 Cutometer SEM 575의 △R7 값으로 기재하였는데 R7 값은 피부의 점탄성(viscoelasticity)을 나타낸다. 표 10과 같이 제조예 1 내지 4를 도포한 경우에 피부 탄력개선 효과가 우수함을 알 수 있다.Experimental results are described in Table 10 below as ΔR7 values of Cutometer SEM 575, and R7 values indicate viscoelasticity of the skin. As shown in Table 10, it can be seen that when Preparation Examples 1 to 4 were applied, the skin elasticity improvement effect was excellent.

피부탄력개선효과(△R7)Skin elasticity improvement effect (△R7) 제조예1Preparation Example 1 0.380.38 제조예2Preparation Example 2 0.350.35 제조예3Preparation 3 0.340.34 제조예4Preparation 4 0.330.33 비교예1Comparative Example 1 0.220.22 비교예2Comparative Example 2 0.240.24

이하, 상기한 실험예들의 결과를 근거로 하여 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 함유하는 화장료를 조성하여 하기와 같이 제시한다. 그러나 본 발명의 조성물이 하기의 제형예에 한하여 제한되는 것은 아니다.Hereinafter, based on the results of the above experimental examples, a cosmetic composition containing a tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract is formulated and presented as follows. However, the composition of the present invention is not limited to the following formulation examples.

< 제형예 1 > 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 함유하는 토너의 제조<Formulation Example 1> Preparation of toner containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract as an active ingredient

실시예 1 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 함유한 화장료 중 토너의 처방예는 표 11과 같다.Example 1 Table 11 shows toner formulation examples in cosmetics containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract.

번호number 원료Raw material 함량(중량%)content (wt%) 원료내함량비율(%)Raw material content ratio (%) 1One 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물Tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract 2.002.00 22 글리세린glycerin 5.005.00 33 메틸프로판디올methyl propanediol 3.003.00 44 베타인betaine 1.001.00 55 폴리글리세릴-10올리에이트Polyglyceryl-10 Oleate 0.500.50 44%44% 폴리글리세릴-10스테아레이트Polyglyceryl-10 Stearate 56%56% 66 1,2-헥산디올1,2-Hexanediol 1.201.20 77 디소듐이디티에이Disodium EDIT 0.020.02 88 방부제antiseptic 미량a very small amount 99 향료Spices 미량a very small amount 1010 정제수Purified water 잔량remaining amount

< 제형예 2 > 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 함유하는 로션의 제조<Formulation Example 2> Preparation of lotion containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract as an active ingredient

실시예 1 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 함유한 화장료 중 로션의 처방예는 표 12와 같다.Example 1 A formulation example of a lotion in a cosmetic containing a tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract is shown in Table 12.

번호number 원료Raw material 함량(중량%)content (wt%) 원료내함량비율(%)Raw material content ratio (%) 1One 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물Tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract 2.002.00 22 카프릴릭/카프릭트리글리세라이드Caprylic/Capric Triglycerides 5.005.00 33 세테아릴알코올cetearyl alcohol 1.001.00 44 스테아릭애씨드Stearic Acid 0.500.50 55 글리세린glycerin 5.005.00 66 메틸프로판디올methyl propanediol 3.003.00 77 프로판디올propanediol 3.003.00 88 디메치콘dimethicone 0.500.50 99 사이클로펜타실록산Cyclopentasiloxane 1.001.00 65%65% 사이클로헥사실록산Cyclohexasiloxane 35%35% 1010 세테아릴올리베이트cetearyl olivate 1.001.00 50-70%50-70% 솔비탄올리베이트Sorbitan Oliveate 35-50%35-50% 1111 폴리글리세릴-3메틸글루코오스다이스테아레이트Polyglyceryl-3 methylglucose distearate 1.001.00 1212 1,2-헥산디올1,2-Hexanediol 1.201.20 1313 글리세릴스테아레이트Glyceryl Stearate 0.500.50 1414 폴리솔베이트60Polysorbate 60 0.300.30 1515 트로메타민tromethamine 0.180.18 1616 디소듐이디티에이Disodium EDIT 0.020.02 1717 암모늄아크릴로일다이메틸타우레이트/브이피코폴리머Ammonium acryloyldimethyl taurate/vpicopolymer 0.100.10 1818 소듐폴리아크릴레이트Sodium Polyacrylate 0.100.10 55-65%55-65% 하이드로제네이티드폴리데센Hydrogenated Polydecene 30-40%30-40% 트라이데세스-6Trideces-6 < 5%< 5% 1919 카보머Carbomer 0.100.10 2020 잔탄검xanthan gum 0.050.05 2121 방부제antiseptic 미량a very small amount 2222 향료Spices 미량a very small amount 2323 정제수Purified water 잔량remaining amount

< 제형예 3 > 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 유효성분으로 함유하는 크림의 제조<Formulation Example 3> Preparation of cream containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract as an active ingredient

실시예 1 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물을 함유한 화장료 중 크림의 처방예는 표 13과 같다.Example 1 A formulation example of a cream in a cosmetic containing a tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract is shown in Table 13.

번호number 원료Raw material 함량(중량%)content (wt%) 원료내함량비율(%)Raw material content ratio (%) 1One 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드 혼합추출물Tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid mixed extract 2.002.00 22 카프릴릭/카프릭트리글리세라이드Caprylic/Capric Triglycerides 7.007.00 33 다이카프릴릴카보네이트Dicaprylyl Carbonate 3.003.00 44 세테아릴알코올cetearyl alcohol 2.002.00 55 스테아릭애씨드Stearic Acid 0.200.20 66 글리세린glycerin 5.005.00 77 프로판디올propanediol 5.005.00 88 디메치콘dimethicone 0.500.50 99 사이클로펜타실록산Cyclopentasiloxane 1.001.00 65%65% 사이클로헥사실록산Cyclohexasiloxane 35%35% 1010 1,2-헥산디올1,2-Hexanediol 1.201.20 1111 트레할로스Trehalose 0.500.50 1212 글리세릴스테아레이트시트레이트Glyceryl Stearate Citrate 3.003.00 1313 글리세릴스테아레이트Glyceryl Stearate 0.300.30 1414 폴리솔베이트60Polysorbate 60 0.300.30 1515 트로메타민tromethamine 0.180.18 1616 디소듐이디티에이Disodium EDIT 0.020.02 1717 암모늄아크릴로일다이메틸타우레이트/브이피코폴리머Ammonium acryloyldimethyl taurate/vpicopolymer 0.100.10 1818 소듐폴리아크릴레이트Sodium Polyacrylate 0.400.40 55-65%55-65% 하이드로제네이티드폴리데센Hydrogenated Polydecene 30-40%30-40% 트라이데세스-6Trideces-6 < 5%< 5% 1919 카보머Carbomer 0.200.20 2020 잔탄검xanthan gum 0.050.05 2121 소듐하이알루로네이트Sodium Hyaluronate 0.0050.005 2222 방부제antiseptic 미량a very small amount 2323 향료Spices 미량a very small amount 2424 정제수Purified water 잔량remaining amount

본 발명을 첨부된 도면과 함께 설명하였으나, 이는 본 발명의 요지를 포함하는 다양한 실시 형태 중의 하나의 실시 예에 불과하며, 당 업계에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 하는 데에 그 목적이 있는 것으로, 본 발명 은 상기 설명된 실시예에만 국한되는 것이 아님은 명확하다. 따라서, 본 발명의 보호범위는 하기의 청구범위에 의해 해석되어야 하며, 본 발명의 요지를 벗어나지 않는 범위 내에서 변경, 치환, 대체 등에 의해 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리에 포함될 것이다. 또한, 도면의 일부 구성은 구성을 보다 명확하게 설명하기 위한 것으로 실제보다 과장되거나 축소되어 제공되는 것임을 명확히 한다.Although the present invention has been described in conjunction with the accompanying drawings, this is only one embodiment of various embodiments including the gist of the present invention, and is intended to be easily implemented by those of ordinary skill in the art. For the purpose, it is clear that the present invention is not limited to the embodiments described above. Accordingly, the protection scope of the present invention should be interpreted by the following claims, and all technical ideas within the scope equivalent to that by changes, substitutions, substitutions, etc. within the scope not departing from the gist of the present invention are in the right of the present invention. will be included In addition, it is clarified that some components of the drawings are provided in an exaggerated or reduced form than in reality for more clearly explaining the configuration.

Claims (4)

티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 각각 0.0001 ~ 40.0%의 중량비로 혼합하여 추출 용매를 첨가하고, 60 ~ 90℃조건에서 4시간씩 3회 환류추출하고, 실온으로 냉침하고, 여과하여, 감압농축 및 동결 건조한 혼합추출물을 유효성분으로 하는 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 함유한 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 갖는 화장료 조성물.
Tea tree leaf, mugwort, buckwheat, and capryloyl salicylic acid were mixed in a weight ratio of 0.0001 to 40.0%, respectively, an extraction solvent was added, extracted under reflux 3 times at 60 to 90 ° C. for 4 hours, and cooled to room temperature. A cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid, which is a mixed extract concentrated under reduced pressure and freeze-dried by filtration, as an active ingredient .
삭제delete 제 1항에 있어서,
상기 추출물은 물, 탄소수 1 내지 4개의 무수 또는 함수 저급 알코올, 에틸 아세테이트, 글리세린 및 에틸렌글리콜로 구성된 군으로부터 선택되는 어느 하나 또는 둘 이상 혼합된 추출 용매를 사용하여 추출하는 것을 특징으로 하는 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 함유한 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 갖는 화장료 조성물.
The method of claim 1,
The extract is water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, ethyl acetate, glycerin, and tea tree leaf, characterized in that the extraction is performed using any one or a mixture of two or more extraction solvents selected from the group consisting of ethylene glycol , mugwort, buckwheat and capryloyl salicylic acid, a cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects.
제 1항에 있어서,
상기 화장료 조성물은 화장수, 스킨, 로션, 크림, 파운데이션, 에센스, 젤, 팩, 유화형 자외선 차단용 크림, 유화형 파운데이션, 유화형 메이크업 베이스, 오일케익형 파운데이션, 투웨이케익, 또는 파우더 팩트의 제형으로 제형화하는 것을 특징으로 하는 티트리잎, 쑥, 메밀 및 카프릴로일살리실릭애씨드를 함유한 항산화, 항염, 피부진정, 재생, 탄력 및 보습 효과를 갖는 화장료 조성물.
The method of claim 1,
The cosmetic composition is in the form of a lotion, skin, lotion, cream, foundation, essence, gel, pack, emulsified sunscreen cream, emulsified foundation, emulsified makeup base, oil cake-type foundation, two-way cake, or powder pact. A cosmetic composition having antioxidant, anti-inflammatory, skin soothing, regenerating, elastic and moisturizing effects containing tea tree leaf, mugwort, buckwheat and capryloyl salicylic acid, characterized in that it is formulated.
KR1020210071390A 2021-06-02 2021-06-02 Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid KR102343166B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210071390A KR102343166B1 (en) 2021-06-02 2021-06-02 Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210071390A KR102343166B1 (en) 2021-06-02 2021-06-02 Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid

Publications (1)

Publication Number Publication Date
KR102343166B1 true KR102343166B1 (en) 2021-12-28

Family

ID=79177927

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210071390A KR102343166B1 (en) 2021-06-02 2021-06-02 Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid

Country Status (1)

Country Link
KR (1) KR102343166B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116549512A (en) * 2023-07-12 2023-08-08 江西瑞秀朗科技有限公司 Compound essential oil for treating acne and pharmaceutical composition containing compound essential oil
KR102609649B1 (en) * 2023-07-07 2023-12-05 한국콜마주식회사 Cosmetic composition comprising high amount of capryloyl salicylic acid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140071570A (en) * 2012-11-30 2014-06-12 주식회사 매직신기한비누 Natural soap composition that contains herbal extracts and herbal powders for skin improvement
KR102033088B1 (en) 2017-12-08 2019-10-17 스킨큐어 주식회사 Composition comprising Plant Extract Complex for Anti-bacteria, Anti-inflammation, Anti-oxidation, Inhibiting Sebum Secretion and Improving Dermatitis
KR102227355B1 (en) * 2020-08-03 2021-03-11 민디선 민 Complex cosmetic composition for non-irritating weak acid exfoliation and epithelial cell nutrition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140071570A (en) * 2012-11-30 2014-06-12 주식회사 매직신기한비누 Natural soap composition that contains herbal extracts and herbal powders for skin improvement
KR102033088B1 (en) 2017-12-08 2019-10-17 스킨큐어 주식회사 Composition comprising Plant Extract Complex for Anti-bacteria, Anti-inflammation, Anti-oxidation, Inhibiting Sebum Secretion and Improving Dermatitis
KR102227355B1 (en) * 2020-08-03 2021-03-11 민디선 민 Complex cosmetic composition for non-irritating weak acid exfoliation and epithelial cell nutrition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102609649B1 (en) * 2023-07-07 2023-12-05 한국콜마주식회사 Cosmetic composition comprising high amount of capryloyl salicylic acid
CN116549512A (en) * 2023-07-12 2023-08-08 江西瑞秀朗科技有限公司 Compound essential oil for treating acne and pharmaceutical composition containing compound essential oil
CN116549512B (en) * 2023-07-12 2023-10-27 江西瑞秀朗科技有限公司 Compound essential oil for treating acne and pharmaceutical composition containing compound essential oil

Similar Documents

Publication Publication Date Title
KR102171133B1 (en) Skin external composition comprising centella asiatica extract and papaver rhoeas extract
KR101425031B1 (en) Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil
KR20170103172A (en) Cosmetic compositions containing centella asiatica extract, ceramide and betula alba juice for relieving skin irritation and reinforcing skin barrier
KR102343166B1 (en) Cosmetic composition having anti-oxidant, anti-inflammatory, skin soothing, regeneration, elasticity and moisturizing effects which comprise Melaleuca Alternifolia (Tea Tree) Leaf, Artemisia Princeps Leaf, Polygonum Fagopyrum (Buckwheat) Seed and Capryloyl Salicylic Acid
KR100947638B1 (en) Composition comprising lava seawater salt
KR101100678B1 (en) Cosmetic Composition comprising plant extracts
KR101078888B1 (en) A cosmetic composition comprising tissue cultured Echinaceae adventitious roots and an preparing method thereof
KR102026399B1 (en) Cosmetic composition for skin Humectant comprising Opuntia Ficus-Indica fruit extract and mixed compound of panthenol, hyaluronic acid and betaine
KR102350141B1 (en) A Cosmetic Composition for Skin protection and Alleviation of skin irritation Comprising Extract of Portulaca oleracea, Artemisia argyi and Rhodiola rosea
KR20150112103A (en) Compositions for improving skin conditions comprising plant extracts or fractions thereof
CN115192501B (en) Cosmetic composition for protecting skin comprising extracts of rice, reed, corn silk, mallow and aloe
KR101574248B1 (en) Cosmetic composition comprising Reynoutria sachalinensis extracts for skin anti-wrinkle effect
KR102628844B1 (en) Cosmetic composition for anti-oxidation, skin whitening and anti-wrinkle containing a mixed fermentation extracts of Wisteria floribunda flowers, Aralia elata flowers, Camellia japonica leafs and Camellia japonica flowers as effective component
KR20200129888A (en) Cosmetic composition containing black kelp
KR102400090B1 (en) Cosmetic Composition for Reducing Skin Wrinkle
KR100816265B1 (en) Cosmetic Composition for Abirritating Skin Containing Extract of Rheum undulatum as Active Ingredient
KR102127771B1 (en) A composition for antioxidation, anti-inflammation, antiaging or skin soothing comprising herb complex extracts
KR20130033228A (en) Composition of cosmetic and treating skin disease
KR100946584B1 (en) Cosmetic Composition Comprising Poncirus trifoliata fruit extract and Nymphaea caerulea extract
KR20210024268A (en) Cosmetic composition containing centella asiatica extract, ceramide and betula alba juice for relieving skin irritation and reinforcing skin barrier
KR20160061601A (en) Cosmetic composition and pharmaceutical composition containing the extract of Corchorus olitorius L, ginko and chlorella
KR102233707B1 (en) Cosmetic composition comprising natural extract and natural powder
KR20150052907A (en) Cosmetic composition for Improving Skin Moisturization Comprising the mixed extract of Peach blossom, Sophora japonica flower, Rhubarb and Clove buds as active ingredient
KR101033814B1 (en) Cosmetic composition containing Saponaria officinalis extract for removing Black Head
KR102723456B1 (en) A cosmetic composition comprising a mixed extract of mistletoe, plantain, mallow and okra as an active ingredient, and a method for manufacturing the same

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant